Patients studied and methods Ten women aged 28 to 72 (mean 49 5) years and one man aged 62 years were treated. Their clinical features are shown in Table I . The known duration of their disease ranged from 8 months to 20 years and included all grades of severity. The degree of systemic involvement was investigated in all patients and forms the basis of separate reports (Bluestone, MacMahon, and Dawson, 1968; Godfrey, Bluestone, and Higgs, 1968; Thompson, Bluestone, Bywaters, Dorling, and Johnson, 1968) .
For the purposes of this trial the following observations were used: (1) Patients' subjective symptoms, in particular skin tightness and Raynaud's phenomenon. (2) An estimate of the degree of clinical skin involvement, telangiectasia, and pigmentation. (Pickering, 1933) .
(5) Maximum grip strengths (Savage, Davis, Chapman, Propert, Robertson, and Copeman 1958) , writing-time, and palm-print areas (Ansell and Bywaters, 1953) were recorded. A change of over 30 per cent. in right or left palmar contact area for better or worse during the assessment period was considered significant. In order to investigate more accurately the physical properties of the skin in this disease, a suction cup was applied to the intact skin of the dorsum of the right hand and the distortion produced in response to a series of pre-determined negative pressures was measured (Grahame and Holt, 1969) (Fig. 1) . Applying the appropriate formulae (Tregear, 1966) established by the use of Harpenden calipers (Tanner and Whitehouse, 1955) , the gradient (T/S) represents the Elastic Modulus (Y) for intact skin (Fig. 2) . In scleroderma it is often not possible to measure skin thickness with calipers because of cutaneous tethering to underlying tissues, and formal measurement of skin elasticity is thus impossible. Nevertheless, in these circumstances, it is possible to obtain data for stress x thickness (Td) and strain (S) and thereby to construct a Td/S curve. With healthy skin the resultant Td/S curve has a characteristic form. Initially there is considerable strain in response to comparatively little stress. This is due to the take-up of slack. After approximately 5 per cent. strain is achieved, further increases in stress result in relatively little increase in strain. From this point the relationship is virtually linear. The emergence of a stress/ strain curve the general shape of which conforms to the normal pattern (Fig. 2) depends on the unimpeded movement of the skin as a free diaphragm (Grahame, 1969) . In scleroderma the skin tethering abolishes free movement and abnormally shaped curves result: viz. horizontal lines, U-shapes, and zig-zag shapes (Fig. 3 ). Presumably this is because the formulae used to calculate the results are inappropriate in any situation in which movement as a free diaphragm cannot occur. Thus the 9, reversion to normal of a previously abnormal result obtained in testing the same area of skin implies a significant lessening in the degree of tethering.
Observations on the above clinical criteria were made at 3-monthly intervals for the duration of treatment and approximately 1 year after the end of treatment. In vivo skin elasticity was measured serially in ten patients. Collagen estimations were performed on pre-and posttreatment skin samples taken from adjacent sites on the dorsum of the hand in eight patients (these will be reported separately). Drug schedule D-penicillamine hydrochloride was started at a low dose (150 mg./day) incleasing gradually over the first month to a maximum tolerated dose of up to 3g./day. Pyridoxine 30 mg./day was given in addition, in view of the antivitamin B6 effect of penicillamine (Jaffe, Altman, and Merryman, 1964) . Regular blood counts and urine tests were performed throughout the duration of treatment, to detect toxic effects such as thrombocytopenia or albuminuria.
Results
One patient (Case 6) died from her severe illness while abroad and the effect of treatment could not be assessed. A further patient (Case 8) had to stop treatment after a few days because of side-effects. These two patients are not included in the discussion. The remaining nine patients were treated for 5 to 15 months (mean 9-2) with maximum daily doses of 1 -5 to 3g. (average 2-4). The results of therapy in these nine patients are shown in Table II (Fig. 3) gave bizarre curves not conforming to recognized patterns and therefore comparable with tethering. After treatment (of minimum duration 4 months), however, these same six patients showed stress-strain curves approaching a normal configuration (Fig. 4) , indicating a reduced tethering effect or none. Of great interest was the finding that, at the final follow-up, 9, 10, and 18 months respectively after the end of treatment, three of these patients still had normal stress/strain curves (Table II) . In two others (at 12 and 21 months respectively) the curves became abnormal again. The sixth patient was not available for study. The other five patients had persistently abnormal stress-strain curves. Four untreated patients with systemic sclerosis measured serially over similar periods showed no such shift to normality.
Three patients (Cases 1, 9, and 11) had treatment stopped because of persistent proteinuria up to 600 mg./day (although other tests of renal function were unchanged). Two patients (Cases 4 and 10) were reluctant to continue taking penicillamine because of persistent side-effects and lack of subjective improvement. One patient (Case 2) had to stop treatment because of gross dysphagia necessitating a gastrotomy.
Rash and/or pruritis was seen in three patients, dyspepsia and/or anorexia in five, fever in four, general malaise in three, proteinuria in three, limb and joint pains in two, and taste disturbances in one.
No patients developed blood dyscrasias. It was found that subjective side-effects were usually abated by temporarily lowering the daily dose to tolerated levels and slowly increasing it again. Probably fewer side-effects would have occurred if we had started with lower doses and increased the dosage more gradually. However, rash and disturbances of taste occurred at relatively low dosages. 
PALM-PRINT AREAS
The palm-print areas tended to rema or become worse during the course (Table II) . In four patients, howev improvement was apparent. In three provement occurred after treatment these three patients also maintained elasticity tests after treatment. T patient whose palm-print area imp treatment later deteriorated in both and palm-print assessment. The associ changes in vivo in skin elasticity ar areas appears to be close. (Grahame, of trea.tment 1969) which in systemic sclerosis, can be used to er, significant monitor the presence or absence of dermal tethering.
SIDE-EFFECTS
of these im-This test has shown a definite change towards t had ended; normality (with normal stress-strain curves) in six Inormal skin out of nine patients, appearing within 5 months ofhe remaining treatment and persisting after treatment finished in roved during three patients. However, once tethering has been skin elasticity eliminated, it ceases to be of use as an index of iation between continuing improvement. Palm-print areas may then nd palm-print become the most helpful method of assessment.
The correlation between palm-print areas, the only other measurement to show significant change, and skin elasticity tests, is interesting, but the patients. One reason for the delay in appearance of improvement severe malaise in palm-print areas is not clear. It is unlikely that )r a few days. the three cases involved had undergone spontaneous. X.I. improvement. The delay may be due to a sustained effect of penicillamine, in which case we may expect at a later date to find continuing improvement in the absence of further treatment. We could find no correlation between the effect of penicillamine and age of patient, duration or severity of disease, or dosage of penicillamine.
Abnormal stress/strain curves were found in sclerodermatous patients even when the skin appeared clinically normal; this also occurred in four out of ten patients with digital arteritis but without clinical evidence of cutaneous sclerosis (Fig. 5) (Grahame, 1969) . Improvement in the skin may not necessarily be associated with improvement in the systemic lesions. In particular it is hard to visualize improvement in the severe vascular sclerosis found in some patients. The effect of penicillamine on the collagen of systemic organs is unknown, and this may prove to be a limiting factor in the long-term use of penicillamine. Preliminary observations suggesting that skin collagen synthesis is greater than normal in areas of obvious scleroderma, and particularly when this is active (Keiser and Sjoerdsma 1969) , suggest that earlier treatment before fibrosis and calcification are advanced might improve the results obtained.
As in other reports (Scheinberg, 1964; Jaffe, 1965; Henkin, Keiser, Jaffe, Stemlieb, and Scheinberg, 1967; Rosenberg and Hyslett, 1967) , sideeffects were frequent and, in some cases, severe enough to necessitate withdrawal of the drug. In view of renal damage due to the drug (Stemlieb, 1966; Rosenberg and Hayslett, 1967) and the absence of clinical benefit, we have regarded the appearance of persistent proteinuria as an indication for ceasing therapy, although in life-saving situations (e.g. Wilson's disease), this side-effect may be acceptable and is apparently non-progressive- (Walshe, 1968) . We suggest that in future smaller doses of penicillamine should be given for a more prolonged period, thus reducing the incidence of side-effects. Summary D-penicillamine was given to eleven patients with scleroderma, nine of whom were able to continue treatment. Although clinically no benefit was obvious, improvement was found in the skin tethering in six patients by means of a new test and also in the palm-print areas in four patients. This improvement has so far been maintained for up to 18 months after the end of treatment. It is suggested that further trials with penicillamine in a lower dosage and for a more prolonged period might be indicated. RtSUME SUMARIO Le traitement de la sclerose systemique avec la penicillamine-D Une nouvelle methode pour observer les effets du traitement La penicillamine-D a e donne'a onze malades atteints de scl6rodermie; neuf d'entre les quels ont pu continuer le traitement. Malgre qu'aucun avantage clinique n'etait evident, une amelioration a ete remarque dans les attaches de la peau chez six malades au moyen d'un nouveau test et aussi par les empreintes des regions palmaires chez quatre malades. Cette amelioration a e jusqu'ici maintenue pendant 18 mois apres la fin du traitement. II est suggere que d'autres essais avec la penicillamine 'a un dosage moindre et donnee pendant une periode plus longue peuvent etre indiques.
Tratamiento de la esclerosis sist6mica con penicilamina D Un nuevo metodo para observar los efectos del tratamiento Se administr6 penicilamina D a once pacientes con escleroderma, nueve de los cuales pudieron continuar el tratamiento. Si bien clinicamente no se evidenci6 ninguin beneficio, se noto mejora en la adherencia de piel en seis pacientes por medio de una nueva prueba, y tambien en regiones de la palma de la mano en cuatro pacientes. Hasta ahora, esta mejoria se ha mantenido por periodos de hasta 18 meses despues de terminar el tratamiento. Se sugiere la conveniencia de realizar otros experimentos con penicilamina en menor dosis y por un periodo mas prolongado.
